| Literature DB >> 33860138 |
Nobuaki Hoshino1, Yudai Fukui1, Koya Hida1, Kazutaka Obama1.
Abstract
AIM: Randomized controlled trials (RCT) are the gold standard in surgical research, and case-matched studies, such as studies with propensity score matching, are expected to serve as an alternative to RCT. Both study designs have been used to investigate the potential superiority of laparoscopic surgery to open surgery for rectal cancer, but it remains unclear whether there are any differences in the findings obtained using these study designs. We aimed to examine similarities and differences between findings from different study designs regarding laparoscopic surgery for rectal cancer.Entities:
Keywords: case‐matched study; low anterior resection; randomized controlled trial; rectal cancer
Year: 2020 PMID: 33860138 PMCID: PMC8034685 DOI: 10.1002/ags3.12409
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
Figure 1Flow diagram of study selection Central Register of Controlled Trials (CENTRAL)
Patient characteristics
| Study | Setting |
Prospective/ Retrospective | Study period | Surgical procedures | Patients, n | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | Institution | Start | End | Laparoscopy | Open | ||||||||||||
| Randomized controlled trials | |||||||||||||||||
| ACOSOG | International | Multi | Prospective | 2008/10 | 2013/9 | LAR, APR, HP, TC | 240 | 222 | |||||||||
| ALaCaRT | International | Multi | Prospective | 2010/3 | 2014/11 | LAR, APR | 238 | 235 | |||||||||
| COLAR II | International | Multi | Prospective | 2004/1 | 2010/5 | AR, APR, HP | 699 | 345 | |||||||||
| COREAN | Korea | Multi | Prospective | 2006/4 | 2009/8 | LAR, APR | 170 | 170 | |||||||||
| Braga 2007 | Italy | Single | Prospective | NR | NR | LAR, APR | 83 | 85 | |||||||||
| Case‐matched studies | |||||||||||||||||
| da Luz Moreira 2011 | USA | Single | Retrospective | 1992 | 2008 | LAR, APR | 91 | 91 | |||||||||
| de’Angelis 2017 | International | Multi | Retrospective | 2005/1 | 2015/12 | LAR, APR | 52 | 52 | |||||||||
| Guo 2015 | China | Single | Retrospective | 2007/4 | 2013/12 | LAR, APR | 191 | 191 | |||||||||
| Katsuno 2016 | Japan | Multi | Prospective | 2010/6 | 2013/2 | LAR | 209 | 209 | |||||||||
| Koulas 2009 | Greece | Single | Retrospective | 1998/10 | 2006/12 | AR, ISR, APR | 57 | 60 | |||||||||
| Manchon‐Walsh 2019 | Spain | Multi | Retrospective | 2011 | 2012 | AR,APR, HP | 842 | 517 | |||||||||
| Milone 2017 | Italy | Multi | Retrospective | 2009/1 | 2015/12 | AR, APR | 242 | 235 | |||||||||
| Nussbaum 2015 | USA | Multi | Retrospective | 2010 | 2011 | LAR | 6430 | 6430 | |||||||||
| Park 2013 | Korea | Single | Retrospective | 2003/1 | 2008/11 | AR, ISR, APR | 406 | 406 | |||||||||
| Tayar 2018 | Brazil | Single | Retrospective | 2008 | 2012 | LAR | 50 | 50 | |||||||||
| Cohort studies | |||||||||||||||||
| Allaix 2016 | Italy | Single | Retrospective | 1994/4 | 2005/8 | AR, APR | 153 | 154 | |||||||||
| Anthuber 2003 | Germany | Single | Retrospective | 1996/1 | 2002/3 | AR, APR, HP | 101 | 334 | |||||||||
| Du 2017 | China | Single | Retrospective | 2015/1 | 2017/1 | AR | 80 | 70 | |||||||||
| Kellokumpu 2012 | Finland | Single | Retrospective | 1999/1 | 2006/12 | HAR, LAR, APR | 100 | 91 | |||||||||
| Kim 2015 | Korea | Single | Retrospective | 2002/1 | 2011/12 | AR | 131 | 176 | |||||||||
| Laurent 2009 | France | Single | Retrospective | 1994/1 | 2006/12 | AR, APR, HP | 238 | 233 | |||||||||
| Law 2009 | China | Single | Retrospective | 2000/6 | 2006/12 | AR, APR, HP | 111 | 310 | |||||||||
| Lee 2013 | Korea | Single | Retrospective | 2001/6 | 2008/12 | LAR | 80 | 80 | |||||||||
| Li 2010 | China | Multi | Prospective | 2005/6 | 2007/6 | AR, APR | 65 | 70 | |||||||||
| Li 2011 | China | Single | Retrospective | 2000/1 | 2005/6 | AR, APR | 113 | 123 | |||||||||
| Li 2015 | China | Single | Retrospective | 2003/1 | 2008/12 | AR, APR | 129 | 152 | |||||||||
| Liu 2016 | China | Single | Retrospective | 2011 | 2013 | AR, APR | 84 | 65 | |||||||||
| Mohamed 2014 | China | Single | Retrospective | 2000/1 | 2011/12 | AR, APR, HP | 470 | 593 | |||||||||
| Pan 2016 | China | Single | Retrospective | 2009/1 | 2012/12 | AR, APR | 85 | 102 | |||||||||
| Staudacher 2007 | Italy | Single | Retrospective | 1998/1 | 2005/9 | AR | 108 | 79 | |||||||||
| Strouch 2013 | USA | Single | Retrospective | 2005/1 | 2011/6 | LAR | 75 | 75 | |||||||||
| Wu 2018 | China | Single | Retrospective | 2009/1 | 2013/12 | LAR, APR, HP | 277 | 614 | |||||||||
| Yang 2013 | China | Single | Retrospective | 2010/5 | 2012/5 | LAR, APR | 87 | 90 | |||||||||
| Zhang 2019 | China | Single | Retrospective | 2008/1 | 2011/12 | AR, CAA | 112 | 116 | |||||||||
| Zhou 2014 | China | Single | Retrospective | 2005/1 | 2008/1 | LAR, APR | 57 | 65 | |||||||||
Abbreviations: APR, abdominoperineal resection; AR, anterior resection; CAA, colo‐anal anastomosis; HAR, high anterior resection; HP, Hartmann’s procedure; ISR, intersphincteric resection; LAR, low anterior resection; NR, not reported; TC, total colectomy.
Summary of meta‐analyses based on study designs
| Outcomes | Measures | Randomized controlled trials | Case‐matched studies | Cohort studies | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Patients |
Point estimation | 95% CI | Study | Patients |
Point estimation | 95% CI | Study | Patients |
Point estimation | 95% CI | ||
| n | n | n | n | n | n | ||||||||
| Short‐term | |||||||||||||
| Postoperative overall complications | RR | 4 | 2012 | 1.00 | 0.89, 1.12 | 6 | 2939 | 0.91 | 0.83, 1.01 | 14 | 4930 | 0.76 | 0.67, 0.87 |
| Anastomotic leakage | RR | 5 | 2144 | 1.11 | 0.78, 1.57 | 6 | 1986 | 1.05 | 0.79, 1.39 | 16 | 5126 | 0.98 | 0.77, 1.24 |
| Mortality | RD | 5 | 2487 | −0.00 | −0.01, 0.00 | 7 | 15 799 | −0.00 | −0.01, 0.00 | 12 | 4645 | −0.00 | −0.01, −0.00 |
| Reoperation | RR | 4 | 2012 | 1.07 | 0.71, 1.61 | 4 | 1745 | 1.21 | 0.67, 2.19 | 8 | 3291 | 0.82 | 0.60, 1.13 |
| Length of stay | MD | 2 | 630 | −1.83 | −5.74, 2.07 | 7 | 3056 | −2.96 | −4.50, −1.42 | 8 | 2059 | −2.15 | −3.38, −0.91 |
| Operative time | MD | 3 | 970 | 48.13 | 38.11, 58.14 | 3 | 1298 | −6.32 | −60.17, 47.53 | 10 | 2480 | 13.88 | −1.16, 28.92 |
| Estimated blood loss | MD | 2 | 630 | −116.84 | −234.90, 1.22 | 3 | 1298 | −64.79 | −93.98, −35.60 | 9 | 1680 | −79.71 | −108.05, −51.37 |
| Positive CRMs | RR | 4 | 2163 | 1.25 | 0.81, 1.92 | 4 | 14 644 | 0.75 | 0.65, 0.85 | 6 | 1679 | 1.28 | 0.80, 2.04 |
| Long‐term | |||||||||||||
| 3‐year OS | RR | 3 | 1834 | 1.02 | 0.98, 1.06 | 6 | 2956 | 1.05 | 0.99, 1.10 | 11 | 4367 | 1.06 | 1.00, 1.12 |
| 3‐year DFS | RR | 4 | 2296 | 1.03 | 0.97, 1.09 | 4 | 1480 | 0.99 | 0.94, 1.05 | 6 | 1858 | 0.98 | 0.95, 1.01 |
| 3‐year LRR | RR | 4 | 2002 | 1.05 | 0.66, 1.68 | 2 | 994 | 0.70 | 0.39, 1.25 | 7 | 3243 | 0.64 | 0.47, 0.88 |
Abbreviations: CI, confidence interval; CRM, circumferential resection margin; DFS, disease‐free survival; LRR, local recurrence rate; MD, mean difference; OS, overall survival; RD, risk difference; RR: risk ratio.
Figure 2Results of meta‐analysis stratified by study design: Incidence of postoperative overall complications
Figure 3Results of meta‐analysis stratified by study design: 3‐year local recurrence rate